Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Duke who wrote (2515)	6/10/1999 3:20:00 PM
From: Joe	Read Replies (1) \| Respond to of 4140

I talked to someone that had a copy. It is being tightly held since Sturza charges $1200 for it. I think it was commissioned by the same group of shorts that paid for the Credit Swiss report. Sturza would not tell me if they recommended a sell or a short. Based on market action, my guess is that it was short. Most of the heavy volume on the ask yesterday was NFSC, the MM for Fidelity. If it was institutional selling, they would have not been obvious about the trading, it would have been hidden in INCA or another MM. Since they sat on the best ask all day with 1000 shares indicated and were able to be there all day long, my guess it was a short in a retail or institutional account. I talked with someone in investor relations at SNRS and apparently, Sturza did not even contact the company or any of the clinical investigators when they were doing their "research". A little suspect, wouldn't you say? This was a buying opportunity for me today. Joe